Analysed NUWELLIS INC (NUWE:NASDAQ) News Sources
Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies
16-07-2026
yahoo.com
Nuwellis’ new CEO on building a strong foundation for sustainable value creation
27-07-2026
medicaldevice-network.com
Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth
27-07-2026
yahoo.com
Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy
30-07-2026
yahoo.com
Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
31-07-2026
yahoo.com
Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface
11-08-2026
yahoo.com
Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin
13-08-2026
yahoo.com
Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ...
13-08-2026
yahoo.com
Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical
25-08-2026
yahoo.com
What is the current price of NUWELLIS INC (NUWE:NASDAQ)?
The current price of NUWELLIS INC (NUWE:NASDAQ) is $0.8394.
NUWELLIS INC (NUWE:NASDAQ) absolute price change since previous trading day?
The absolute price change of NUWELLIS INC (NUWE:NASDAQ) since the previous trading day is $-0.0055.
NUWELLIS INC (NUWE:NASDAQ) percentage price change since previous trading day?
The percentage price change of NUWELLIS INC (NUWE:NASDAQ) since the previous trading day is -0.651%.
What is the most recent average sentiment score for NUWELLIS INC (NUWE:NASDAQ)?
The most recent average sentiment score for NUWELLIS INC (NUWE:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for NUWELLIS INC (NUWE:NASDAQ)?
The most recent sentiment for NUWELLIS INC (NUWE:NASDAQ) is .
SEC-8K** Filing Available For NUWELLIS INC (NUWE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.